MSH6 and adrenal cortex carcinoma: In addition, DFS (Disease-free survival) analysis showed that high expression of MSH6 was correlated to poor prognosis for cancers of KIRP (P=0.038), ACC (P=0.00015), UVM (Uveal melanoma) (P=0.038) and LGG (P=0.045) (Figure 2B).